Berliner Boersenzeitung - Six African nations to get own mRNA jab production

EUR -
AED 4.129763
AFN 78.924582
ALL 97.761438
AMD 434.227911
ANG 2.012255
AOA 1031.043687
ARS 1279.999972
AUD 1.741216
AWG 2.02667
AZN 1.891643
BAM 1.949984
BBD 2.270428
BDT 136.622479
BGN 1.958278
BHD 0.423831
BIF 3346.222964
BMD 1.124366
BND 1.454906
BOB 7.786946
BRL 6.352218
BSD 1.124546
BTN 96.01959
BWP 15.216274
BYN 3.680023
BYR 22037.577749
BZD 2.258763
CAD 1.56731
CDF 3228.055466
CHF 0.937856
CLF 0.027574
CLP 1058.118269
CNY 8.106117
CNH 8.111476
COP 4688.607103
CRC 569.002764
CUC 1.124366
CUP 29.795705
CVE 109.937077
CZK 24.888404
DJF 199.8223
DKK 7.460007
DOP 66.262351
DZD 149.582332
EGP 56.266884
ERN 16.865493
ETB 151.437521
FJD 2.544481
FKP 0.846957
GBP 0.841811
GEL 3.080834
GGP 0.846957
GHS 13.832172
GIP 0.846957
GMD 81.519593
GNF 9737.953383
GTQ 8.634246
GYD 235.265567
HKD 8.794286
HNL 29.259723
HRK 7.534603
HTG 147.141104
HUF 402.753615
IDR 18479.352217
ILS 3.98155
IMP 0.846957
INR 95.973424
IQD 1473.105982
IRR 47349.865546
ISK 145.897516
JEP 0.846957
JMD 179.195491
JOD 0.79716
JPY 162.871224
KES 145.290521
KGS 98.325915
KHR 4507.654679
KMF 496.409336
KPW 1011.92959
KRW 1562.351285
KWD 0.345484
KYD 0.937084
KZT 574.326883
LAK 24318.219984
LBP 100757.099452
LKR 337.23409
LRD 224.906145
LSL 20.306031
LTL 3.319961
LVL 0.680118
LYD 6.204493
MAD 10.385622
MDL 19.599104
MGA 5060.064224
MKD 61.529444
MMK 2360.822617
MNT 4018.461898
MOP 9.058662
MRU 44.559088
MUR 51.96847
MVR 17.383003
MWK 1949.944355
MXN 21.714325
MYR 4.82459
MZN 71.848059
NAD 20.306031
NGN 1801.324548
NIO 41.376581
NOK 11.590698
NPR 153.631743
NZD 1.896358
OMR 0.432847
PAB 1.124481
PEN 4.145734
PGK 4.674058
PHP 62.719958
PKR 317.726278
PLN 4.250221
PYG 8982.207641
QAR 4.098674
RON 5.047845
RSD 116.891334
RUB 90.794509
RWF 1610.346744
SAR 4.217405
SBD 9.377696
SCR 16.304071
SDG 675.182671
SEK 10.887458
SGD 1.456283
SHP 0.883575
SLE 25.525902
SLL 23577.397516
SOS 642.702936
SRD 40.981463
STD 23272.110495
SVC 9.83965
SYP 14618.854137
SZL 20.300447
THB 37.261746
TJS 11.610828
TMT 3.940904
TND 3.384505
TOP 2.633381
TRY 43.576496
TTD 7.633231
TWD 33.911554
TZS 3018.923241
UAH 46.798109
UGX 4112.732436
USD 1.124366
UYU 46.910075
UZS 14525.672452
VES 105.922296
VND 29174.492277
VUV 136.185544
WST 3.124079
XAF 654.026512
XAG 0.034758
XAU 0.000348
XCD 3.038656
XDR 0.820038
XOF 654.006214
XPF 119.331742
YER 274.461178
ZAR 20.333373
ZMK 10120.643031
ZMW 30.336836
ZWL 362.045461
  • RBGPF

    1.5000

    64.5

    +2.33%

  • CMSC

    0.1100

    22.16

    +0.5%

  • SCS

    -0.1500

    10.35

    -1.45%

  • AZN

    0.8800

    69.69

    +1.26%

  • CMSD

    0.1090

    22.169

    +0.49%

  • NGG

    1.1500

    72.43

    +1.59%

  • RELX

    0.4600

    55.03

    +0.84%

  • BTI

    0.9400

    43.58

    +2.16%

  • RIO

    -0.2500

    62.39

    -0.4%

  • GSK

    0.3200

    37.96

    +0.84%

  • BCC

    -0.7200

    91.19

    -0.79%

  • BP

    -0.3600

    29.4

    -1.22%

  • RYCEF

    0.2100

    10.91

    +1.92%

  • BCE

    0.0100

    21.57

    +0.05%

  • JRI

    -0.1100

    12.79

    -0.86%

  • VOD

    0.1900

    9.64

    +1.97%

Six African nations to get own mRNA jab production
Six African nations to get own mRNA jab production

Six African nations to get own mRNA jab production

Six African countries have been chosen to establish their own mRNA vaccine production, the World Health Organization said Friday, with the continent largely shut out of access to Covid jabs.

Text size:

Egypt, Kenya, Nigeria, Senegal, South Africa and Tunisia were selected as the first recipients of technology from the WHO's global mRNA vaccine hub, in a push to ensure Africa can make its own jabs to fight the Covid and other diseases.

"More than 80 percent of the population of Africa is yet to receive a single dose. Much of this inequity has been driven by the fact that globally, vaccine production is concentrated in a few mostly high-income countries," WHO chief Tedros Adhanom Ghebreyesus told a ceremony on the sidelines of an EU-Africa summit in Brussels.

"One of the most obvious lessons of the Covid-19 pandemic, therefore, is the urgent need to increase local production of vaccines, especially in low and middle-income countries."

Tedros has continually called for equitable access to vaccines in order to beat the pandemic, and rails against the way wealthy nations have hogged doses, leaving Africa lagging behind other continents in the global vaccination effort.

- Self-reliance -

Currently only one percent of the vaccines used in Africa are produced on the continent of some 1.3 billion people.

The WHO set up a global mRNA technology transfer hub in South Africa last year to support manufacturers in low- and middle-income countries to produce their own vaccines.

The global hub's role is to ensure that manufacturers in those nations have the know-how to make mRNA vaccines at scale and according to international standards.

As used in the Pfizer/BioNTech and Moderna Covid-19 vaccines, mRNA technology provokes an immune response by delivering genetic molecules containing the code for key parts of a pathogen into human cells.

Primarily set up to address the Covid-19 pandemic, the global hub has the potential to expand manufacturing capacity for other vaccines and products, such as insulin to treat diabetes, cancer medicines and, potentially, vaccines for diseases such as malaria, tuberculosis and HIV.

The scheme's ultimate goal is to spread capacity for national and regional production to all health technologies.

"The goal is in 2040 to have reached a level of 60% of vaccines produced in Africa that are administered in Africa," said EU chief Ursula von der Leyen.

- 'Back of the queue' -

The WHO said it would work with the first six countries chosen to develop a roadmap of training and support so they can start producing vaccines as soon as possible. Training will begin in March.

The South African hub is already producing mRNA vaccines at laboratory scale and is currently scaling up towards commercial scale.

But the announcement of the tech transfers does not solve the thorny issue of Covid-19 patents that has set Africa at loggerheads with Europe.

African -- and other developing -- nations are pushing at the World Trade Organization for the temporary intellectual property waiver to allow the generic production of vaccines and treatments.

Europe -- the home of some of the major companies behind the vaccines -- has opposed the move arguing that the first priority was to build up production capacity in poorer countries.

"We are talking about the lives of millions, hundreds of millions of people, rather than the profitability of the few companies," South African President Cyril Ramaphosa said.

"It is not acceptable that Africa is consistently at the back of the queue in relation to access to medicines."

French President Emmanuel Macron pushed back against the calls for a waiver, but mooted other options including "compulsory licensing" that could see the patents used in limited cases.

"We have to be consistent with everything we do, we have to protect intellectual property, because it's very important for us to continue to create, to innovate, to invent," Macron said.

"We have to make sure that this intellectual property never hinders the dissemination of knowledge and the building of its capacities."

(T.Burkhard--BBZ)